Perfusion Systems Market Trends

Increasing prevalence of cardiovascular and respiratory diseases is anticipated to drive the market growth. Cardiovascular and respiratory diseases often lead to tissue damage and organ dysfunction. For instance, according to the Global Initiative for Chronic Obstructive Lung Disease – GOLD, in 2020, the incidence rate of lung cancer was around 2.2 million individuals and is forecasted to increase in the near future. Perfusion systems play a crucial role in the diagnosis and treatment of lung cancer and other chronic ailments by providing a controlled environment for the growth and development of tissues and organs for transplantation.

The increasing prevalence of cardiovascular and respiratory diseases drives the demand for tissue engineering and regenerative medicine, thereby boosting the perfusion systems market for perfusion systems. There is an increasing focus on personalized medicine, tailoring treatments to individual patients' specific characteristics. Perfusion systems play a role in this approach by facilitating the culture and testing of patient-specific cells or tissues for diagnosis and treatment optimization.

With cardiovascular and respiratory diseases being diverse in nature and manifestation, the demand for personalized medicine is set to grow, driving the utilization of perfusion systems. The treatment of cardiovascular and respiratory diseases often involves the use of biologics, such as therapeutic proteins, cell therapies, and gene therapies. Perfusion systems are integral to the bioprocessing of these products, ensuring optimal cell growth, viability, and productivity. Therefore, as the burden of cardiovascular and respiratory diseases continues to rise, the demand for advanced technologies in perfusion systems is anticipated to propel the market growth.